Compositions comprising bacterial strains
Assignee4D Pharma Research Limited
InventorsImke MULDER, Alexander STEVENSON, Helene SAVIGNAC
Life of this patent
Estimating the term…
Abstract
The invention provides compositions comprising bacterial strains for treating and preventing lung injury or lung disease.
Claims21
-17. (canceled)
A method of treating lung injury or lung disease in a subject in need thereof, comprising administering to the subject a pharmaceutical composition comprising a bacterial strain of the genus Blautia, wherein the bacterial strain comprises a polynucleotide sequence of a 16S rRNA gene that has at least 95% sequence identity to the polynucleotide sequence of SEQ ID NO:1, and a pharmaceutically acceptable excipient, diluent, or carrier,
- wherein the lung injury or the lung disease is non-asthma lung injury or non-asthma lung disease.
A method of reducing damage in a lung tissue caused by lung injury or lung disease in a subject in need thereof, comprising administering to the subject a pharmaceutical composition comprising a bacterial strain of the genus Blautia, wherein the bacterial strain comprises a polynucleotide sequence of a 16S rRNA gene that has at least 95% sequence identity to the polynucleotide sequence of SEQ ID NO:1, and a pharmaceutically acceptable excipient, diluent, or carrier,
- wherein the lung injury or the lung disease is non-asthma lung injury or non-asthma lung disease.
Dependencies are inferred from the claim text.